The Endocannabinoid System Targeted Therapeutics Market Is Projected To Grow At An Annualized Rate Of ~30%, Till 2030

>

The endocannabinoid system targeted therapeutics market is projected to grow at an annualized rate of ~30%, till 2030

Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “ covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

 

Key Market Insights

  • More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over180 cannabinoid-derivatives that target the human endocannabinoid signaling system
  • The pipeline features a variety of marketed / clinical stage therapies, being investigated for a wide range of target disease indications and designed for administration via different routes
  • The geographical landscape of this industry is likely to evolve in the next few years as federal authorities legalize the use of medical cannabis across multiple countries
  • Despite the associated stigma, many organizations have extended financial support to aid research efforts in this domain; the focus is on understanding the clinical benefits of endocannabinoid signaling in different diseases
  • The growing interest in this field is also reflected by the 170+ partnerships that have been signed in the last five years, involving both international and indigenous stakeholders, across different geographical marketplaces
  • Presently, North American companies seem to be consolidating their presence indigenously, mostly through strategic acquisitions; key value drivers behind such deals include product and geographical expansion
  • Future market size, based on revenue generation potential of marketed and late stage therapies, is anticipated to be distributed across a variety of therapeutic areas, target receptors and key geographical regions

 

For more information, please visit “Endocannabinoid System Targeted Therapeutics Market, 2020-2030.“

 

Table of Contents

 

  1. PREFACE

1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Chapter Outlines

 

  1. EXECUTIVE SUMMARY

 

  1. INTRODUCTION

3.1.       Chapter Overview

3.2.       Neuropharmacology and Working Mechanism of the Endocannabinoid System

3.3.       Potential Therapeutic Applications of Cannabinoids

3.4.       Legal Aspects and Regulations

3.5.       Existing Challenges

3.6.       Future of Cannabinoid Therapies

 

  1. MARKET LANDSCAPE: ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS

4.1.       Chapter Overview

 

4.2.       Drugs Targeting Endocannabinoid System: Marketed and Development Pipeline

4.2.1.    Analysis by Phase of Development

4.2.2.    Analysis by Target Therapeutic Area

4.2.3.    Analysis by Route of Administration

4.2.4.    Analysis by Dosing Frequency

4.2.5.    Analysis by Target Receptor

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Share:

Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global

Comments

Other related blogs

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

By : Roots Analysis

Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliate..


Medical Device Labels Manufacturing Market, 2019-2030

By : Roots Analysis

To order this detailed 300+ page report, please visit this- https://www.rootsanalysis.com/reports/vi..